Menu
 
Research menu
Jump to menu

Publications:  Dr Ozlem Yildiz

Mao Z, Álvarez-González C, Allen-Philbey K, De Trane S, Yildiz O, Campion T, Adams A, Turner BP et al.(2019). Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies. Multiple Sclerosis and Related Disorders vol. 27, 247-253.
10.1016/j.msard.2018.11.001
https://qmro.qmul.ac.uk/xmlui/handle/123456789/55054
Zubiri I, Lombardi V, Bremang M, Mitra V, Nardo G, Adiutori R, Lu CH, Leoni E et al.(2018). Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis. Molecular neurodegeneration vol. 13, (1)
10.1186/s13024-018-0292-2
https://qmro.qmul.ac.uk/xmlui/handle/123456789/51043
Yildiz O, Mao Z, Adams A, Dubuisson N, Allen-Philbey K, Giovannoni G, Malaspina A, Baker D et al.(2018). Disease activity in progressive multiple sclerosis can be effectively reduced by cladribine. Multiple Sclerosis and Related Disorders vol. 24, 20-27.
10.1016/j.msard.2018.05.010
https://qmro.qmul.ac.uk/xmlui/handle/123456789/42224
Mao Z, Álvarez-Gonzalez C, De Trane S, Yildiz O, Albor C, Doctor G, Soon D, Pepper G et al.(2018). Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?. Multiple Sclerosis Journal - Experimental, Translational and Clinical vol. 4, (2) 2055217318783767-2055217318783767.
10.1177/2055217318783767
https://qmro.qmul.ac.uk/xmlui/handle/123456789/43785
Skripuletz T, Pars K, Schulte A, Schwenkenbecher P, Yildiz Ö, Ganzenmueller T, Kuhn M, Spreer A et al.(2018). Varicella zoster virus infections in neurological patients: a clinical study. BMC Infectious Diseases vol. 18, (1) Article 238,
10.1186/s12879-018-3137-2
Dadak M, Jacobs R, Skuljec J, Jirmo AC, Yildiz Ö, Donnerstag F, Baerlecken NT, Schmidt RE et al. (2017). Gain-of-function STAT1 mutations are associated with intracranial aneurysms. Elsevier BV
10.1016/j.clim.2017.01.012
Pul R, Osmanovic A, Schmalstieg H, Pielen A, Pars K, Schwenkenbecher P, Sühs K, Yildiz Ö et al.(2016). Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See?. International Journal of Molecular Sciences vol. 17, (12) 2106-2106.
10.3390/ijms17122106
Huss AM, Halbgebauer S, Öckl P, Trebst C, Spreer A, Borisow N, Harrer A, Brecht I et al.(2016). Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German–Austrian retrospective multicenter study in patients with a clinically isolated syndrome. Journal of Neurology vol. 263, (12) 2499-2504.
10.1007/s00415-016-8302-1
Yildiz Ö, Pul R, Raab P, Hartmann C, Skripuletz T, Stangel M(2015). Acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome) in a patient with relapse-remitting multiple sclerosis. Journal of Neuroinflammation vol. 12, (1) Article 175,
10.1186/s12974-015-0398-1
Škuljec J, Gudi V, Ulrich R, Frichert K, Yildiz Ö, Pul R, Voss EV, Wissel K et al.(2011). Matrix Metalloproteinases and Their Tissue Inhibitors in Cuprizone-Induced Demyelination and Remyelination of Brain White and Gray Matter. Journal of Neuropathology & Experimental Neurology vol. 70, (9) 758-769.
10.1097/nen.0b013e3182294fad
Gudi V, Škuljec J, Yildiz Ö, Frichert K, Skripuletz T, Moharregh-Khiabani D, Voß E, Wissel K et al.(2011). Spatial and Temporal Profiles of Growth Factor Expression during CNS Demyelination Reveal the Dynamics of Repair Priming. PLoS ONE vol. 6, (7) e22623-e22623.
10.1371/journal.pone.0022623
Return to top